Managers
Lockton Benefit Group has expanded its Private Equity and Corporate Acquisition Practice (PECAP) with the addition of Donald G Harrington, Senior Vice President and director of the practice.
An Associate of Lockton Benefit Group, Harrington is based in New York but has responsibility to integrate the company's private equity transactional services and human capital management of Lockton's clients' businesses across the US. Bob Reiff, President of Lockton Benefit Group said, "Don's background and technical skills are what we needed to lead us into this new chapter."
Ross Reda, Executive Vice President and Chief Operating Officer for Lockton Benefit Group, says:
Quantifind has closed a USD30 million funding round led by global venture capital fund Cathay Innovation. Previous investors Redpoint Ventures, US Venture Partners, Comcast Ventures, Iris Capital and AME Cloud Ventures also joined the round.
This investment will support the company’s growth as it helps marketers understand exactly how their efforts are driving revenue for their respective businesses.
This round of funding, the company’s fourth, will fuel Quantifind’s market expansion efforts, accelerate product development, and allow the company to double staff in its Menlo Park headquarters. Quantifind will focus on growing the sales and customer success teams, as well
PolyPid, an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, has closed a USD22 million private equity financing.
The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company's board of directors, as well as other existing shareholders. 

The new investment is expected to facilitate the completion of an ongoing confirmatory European clinical trial in severe open tibia fractures for BonyPid-1000™, the company’s proprietary investigational doxycycline-loaded synthetic bone substitute, which is planned to be completed by 2017. The
An affiliate of private equity investment firm HIG Capital has acquired a portfolio of compensation product offerings, including Salary.com, from IBM Corporation.
Founded in 1999 and headquartered in Wellesley, Massachusetts, Salary.com is a provider of reliable information, software, and best practices for compensation professionals. The Company’s product offerings help employers find and analyse detailed, real-time, and accurate information about employee compensation, as well as providing a platform for managing their daily workflow.
William Nolan, Managing Director at HIG, says: “We are excited to have the opportunity to invest in Salary.com and work with Kent Plunkett and his team as
Morgan Stanley Alternative Investment Partners (AIP) has closed on over USD225 million in final capital commitments for Private Markets Income Fund I (PMIF).
The fund’s strategy is to invest in niche income-oriented private market strategies, across primary fund commitments, co-investments and secondaries, which provide near-to-medium-term cash distributions. These investment strategies are frequently backed by real, financial or intellectual property assets. While PMIF represented AIP’s first standalone fund in this strategy, AIP has been an active participant in this investment space since 2000.
“Our clients rely on alternative investments to meet many different objectives, and this capital raise demonstrates how
Trilantic Capital Partners Europe has entered into an agreement with Fondazione Salvatore Maugeri (FSM) to make an initial investment of EUR66 million in the company to finance both organic and inorganic growth projects.
As part of the transaction, FSM, a leading Italian operator of private hospitals, will transfer all its operations to a new company. Trilantic Europe will invest in Maugeri through a EUR66 million capital investment and initially will own c. 34% of Maugeri, and FSM will own the remaining circa 66 per cent. Trilantic Europe also has an option to increase its investment to a total of circa
CensorNet has acquired SMS Passcode, a European based multi-factor authentication vendor, and will integrate the unique multi-factor authentication technology into its Unified Security Solution.
The funding for the acquisition was led by Talis Capital alongside existing investors. Hill Dickinson LLP advised investors on the transaction.
This acquisition follows the Series A round completed in September 2015, also led by Talis Capital, and is an important transition for the company. This allows CensorNet to claim a truly global footprint, protecting over one million users across 4,000 customers in 40 countries throughout EMEA and the US.
CensorNet’s management team is
Venture capital investor Octopus Ventures has exited its investment in Vision Direct, the online contact lens retailer. Vision Direct has been acquired by Essilor.
Octopus Ventures invested in Vision Direct in 2009 when the company employed 33 people and has remained the largest shareholder throughout this time, seeing Vision Direct grow to 80 employees with a turnover of GBP33 million. This exit represents the second significant exit for Octopus Ventures in 2016, coming after the recent exit from SwiftKey following its acquisition by Microsoft.
Alex Macpherson, head of Octopus Ventures, says: “Today is a huge day for Vision Direct
Paul Hastings has advised Investindustrial on the launch of Investindustrial Fund VI (Fund VI), the largest ever fund focused primarily on Southern Europe.
The fund will pursue majority investments in quality European mid-market companies typically headquartered in Italy, Spain, Portugal or Switzerland with a strong internationalisation potential.
Fund VI is the first fund of EUR2 billion or more raised for the region and Investindustrial’s funds comprise three of the four funds ever raised in the region of EUR1 billion-plus size.
Funds partner Duncan Woollard led the Paul Hastings team, assisted by funds associate Adam Knight, with associate Nikki Johnstone assisting on the regulatory
The Hilb Group (THG) has acquired Ocean Township, NJ-based PriMed Consulting. The transaction became effective 1 February, 2016.
PriMed Consulting has been providing physicians in New York and New Jersey with medical malpractice insurance for more than 18 years. As the second transaction in 2016 and ninth in the past 12 months, this acquisition will expand THG’s medical malpractice expertise and establish its first location in New Jersey.
"PriMed is a leader in medical malpractice services in New York and New Jersey,” says Bob Hilb, CEO of The Hilb Group. “Their specialty focus goes a long way toward strengthening
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
